Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients

J Heart Lung Transplant. 2018 Aug;37(8):1035-1037. doi: 10.1016/j.healun.2018.04.013. Epub 2018 Apr 25.

Authors

Sarah Schettle¹, Badr Al Bawardy², Rabea Asleh¹, Saadia Sherazi³, Elizabeth Rajan², John Stulak¹, Naveen Pereira¹

Affiliations

¹ Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
³ Cardiovascular Surgery, University of Rochester Medical Center, Rochester, New York, USA.

PMID: 29907501
DOI: 10.1016/j.healun.2018.04.013

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Aged
Angiodysplasia / complications
Angiodysplasia / drug therapy
Blood Transfusion
Cohort Studies
Danazol / therapeutic use*
Female
Gastrointestinal Hemorrhage / drug therapy*
Heart Failure / surgery*
Heart-Assist Devices*
Humans
Male
Middle Aged
Postoperative Complications / drug therapy*
Recurrence

Substances

Danazol